Join us Dec. 1-3 in Nashville for the Digiday Programmatic Marketing Summit
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Mail Metro Media’s next creator play is representing them
Why the Daily Mail’s ad sales team is turning talent agent.
How Celsius doubled down on sports marketing campaigns in 2026
The company is increasingly leveraging partnerships with major sports leagues, college athletics and high-profile athletic events.
In Graphic Detail: Welcome to the agentic commerce quarter
OpenAI, Google, Amazon and Walmart are betting on agent-led holiday shopping. Digiday charts how far it still has to go.